Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...
“More measures are not typically viewed as a good thing. Mostly what you hear about is reductions in measures, fewer better ...
The cleanest case study of pharma and diagnostics operating as one strategic engine is Roche. Instead of treating diagnostics ...
Ten Medicaid tech companies pledge over $600 million in support to help states meet new community engagement requirements and ...
Nearly half of Americans (48%) have used a sleep tracking device within the last year to monitor their sleep quality, ...
A 2024 CMS assessment concluded that “nearly $30 billion in healthcare costs were avoided between 2016 and 2021 related to PQA adherence measures,” Shirley said in an interview with Managed Healthcare ...
A novel recovery index (RI) integrates desaturation degree, recovery time, and supplemental oxygen use, offering prognostic ...
During an investor call, UnitedHealth Group executives talk about the steps it has taken to increase transparency, use ...
In this interview, Emma Kaplan-Lewis, M.D., clinical quality director for HIV, hepatitis and sexual health services at NYC ...
Enhanced ACA premium tax credits were first enacted in 2021 through the American Rescue Plan Act. The policy expanded eligibility for financial assistance above 400% of the federal poverty level and ...
In 2024, the first year Medicare paid for services that address patients’ health-related social needs, most care came from ...
Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results